Yaniv Erlich
CEO of Eleven Therapeutics/A recovering Ivy league Professor. #Hiring
- Role
- Chief Executive Officer at Eleven Therapeutics
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Yaniv Erlich
Prof. Yaniv Erlich is the CEO and co-founder of Eleven Therapeutics. Prior to this postion, he was the CSO of MyHeritage (acquired by Francisco Partners). Before moving to the biotech industry, Prof. Erlich was an Associate Professor of Computer Science at Columbia University and was a PI at the Whitehead Institute, MIT. Prof. Erlich received his bachelor’s degree (summa cum laude from) Tel-Aviv University, Israel (2006) and a PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory (2010). Prof. Erlich authored over 50 peer-reviewed scientific studies and patents, including multiple papers in Science, Nature Genetics, Nature Biotechnology, and Nature Methods, all as a senior author. Prof. Erlich is a TEDMED speaker (2018), the recipient of DARPA’s Young Faculty Award (2017), the Burroughs Wellcome Career Award (2013), Harold M. Weintraub award (2010), the HPC award (2008), and he was selected as one of 2010 Tomorrow’s PIs team of Genome Technology.
Experience
Chief Executive Officer
Oct 2020 — Present · Tel Aviv, IL
Education
Tel Aviv University
Bachelor of Science (BSc), Computational Neuroscience, Summa cum laude
2003 — 2006
Cold Spring Harbor Laboratory
Doctor of Philosophy (PhD), Genomics
2006 — 2010
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.